InMode Ltd. (INMD)
Healthcare
- Fundamental
- 4
- Sentiment
- 4
- Technical
- 4
Bullish only on a confirmed breakout: place a GTC buy stop at 15.30, use 14.98 as the protective stop, scale at 15.94 and 16.42, and do not chase at market below the 15.10-15.27 resistance band.
Company overview
InMode Ltd. is a medical technology company specializing in aesthetic medical devices, offering both less-invasive and non-surgical solutions. The company focuses on minimally invasive procedures using radiofrequency-assisted technologies for body sculpting and skin treatments. InMode also provides non-invasive products for cosmetic concerns such as hair removal and skin revitalization.
Fundamental
goodInMode's valuation is compelling with strong cash flow and balance sheet, but growth and margin uncertainties persist.
InMode is cash-rich and still highly profitable, trading at ~10.62x trailing earnings and ~5.24x EV/EBITDA with ~9.76% free-cash-flow yield and net cash. SEC filings show no going-concern issues, but demand sensitivity, reliance on sales talent, and Israel geopolitical risk are key disclosures; the main fundamental concern is the post-2023 revenue/margin decline and elevated inventory growth. Overall: attractive value with a strong balance sheet, tempered by growth and margin uncertainty.
Sentiment
goodSentiment is influenced by an unsolicited proposal, creating near-term optionality with uncertain outcomes.
INMD is event-driven after confirming receipt of an unsolicited proposal (announced; ongoing_process), introducing near-term optionality with an uncertain outcome. Media sentiment is neutral-to-slightly positive over the last ~14d versus slightly negative in the 30–90d baseline, and the Red-Flag Screen is clean.
Technical
goodTechnical indicators show a bullish trend with strong momentum, though resistance levels suggest caution before entry.
Bullish bias, but conditional: INMD gapped above its 20/50/200-day averages on proposal-driven volume, RSI jumped to 69, ADX is strong, and the MACD histogram flipped positive. The caveats are that MACD remains slightly below zero, Williams %R is near overbought, and nearby resistance from the 15.10-15.27 zone argues against chasing at market.
You’re looking at 2026-06-24 — about 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.